Mission Produce is no longer just an avocado price trade, and that is exactly why the stock looks more interesting than the market is giving it credit for. The business just closed the Calavo acquisition on May 28, then followed it with a $100 million repurchase authorization on June 3, which is a serious capital-allocation signal for a company with an $837.3 million market cap. That combination shifts the conversation from fruit pricing alone to scale, mix, and earnings power. We think that reframe matters more than the headline noise around one weak quarter.
The biggest reason to take AVO seriously here is that management is actively building a broader fresh produce platform, not just riding avocado cycles. Fiscal Q2 revenue reached $290.9 million, with avocado volumes up 15% year over year, even as pricing stayed soft. More important, management guided to Q3 adjusted EBITDA of $28 million to $32 million and second-half fiscal 2026 adjusted EBITDA of $84 million to $88 million, including a partial contribution from Calavo. That is the language of an operator trying to show post-deal earnings capacity, not a company waiting around for avocado prices to bail it out.
The buyback makes that message much harder to ignore. A $100 million authorization is large relative to Mission's current market value, and boards do not approve a program of that size right after a major acquisition unless they believe the stock is undervalued and the balance sheet can support it. That lines up with AVO's TickerSpark Score, where Financial Health sits at 80 and Valuation at 73, a combination that says the company has room to be opportunistic even if profitability is still only middling. At 0.67 times sales and 1.45 times book, the stock is not being priced like a transformed platform story yet.
The insider tape adds another layer of conviction. Over the last roughly 10 transactions, insiders bought 991,842 shares for $11.17 million, with zero sells, and a cluster of those purchases landed in mid-June right after the post-deal reset. That is not token buying. When directors are writing checks that aggressively as the company launches a buyback and starts integrating a strategic acquisition, it usually means they see a gap between current sentiment and the business they expect to emerge over the next few quarters.
That is also why AVO stacks up well against SENEA in this moment. Seneca has the cleaner margin profile today, with a 6.9% net margin versus Mission's 1.8%, but Mission is growing faster, with revenue up 12.7% year over year against SENEA's 5.1%. For a stock still being treated like a low-multiple produce distributor, faster growth plus a fresh capital-allocation catalyst is the more compelling setup.
The weak spot is obvious: this is still an agricultural business with real commodity exposure, and the latest quarter showed it. Mission posted a GAAP net loss of $7.2 million in Q2, missed consensus badly with EPS of negative $0.1017 versus a $0.06 estimate, and remains below both its 50-day and 200-day moving averages. The market has reasons to be skeptical, especially with operating margin at 5.2% and net margin at 1.8%.
Integration risk is real too. Calavo has to be absorbed cleanly, synergies have to show up, and management has to prove that broader scale actually translates into better mix and higher returns. Still, that is exactly why the setup is contrarian rather than obvious. The stock is being judged on near-term avocado price compression and one ugly earnings print even though the strategic shape of the company just changed in a meaningful way.
That leaves AVO looking like a stock we would rather own on the transition than avoid because of the last quarter's messiness. The signal to watch now is not another debate about avocado pricing; it is whether management starts converting the Calavo deal and the buyback into visible EBITDA follow-through. If the company executes against that $84 million to $88 million second-half adjusted EBITDA outlook and begins using the repurchase authorization, the market's old commodity framing should start to break.
We would treat this as a thesis stock, not a sleep-at-night staple. Momentum is still weak, with a Momentum component of just 30 in the TickerSpark Score and the shares underperforming Consumer Defensive by 7.2 percentage points year to date, so this is not the name to oversize. But as a contrarian setup, the ingredients are unusually strong: a broadened platform, a board-backed buyback, and $11.17 million of insider buying with no sells. That is enough for us to side with the transition story over the stale avocado-only narrative.
